1Farb A, Burke AP, Kolodgie FD, et al . Pathological mechanisms of fatal late coronary stent thrombosis in humans[Jl. Circulation,2003,108:1701-1706.
2Frab A, Sangiorgi G, Carter AJ, et al . Pathology of acute and chronic tissue response to coronary stenting in humans[J]. Circulation, 1999,99:44-52.
3Neumarm FJ, Ott I, Gawaz M, et al , Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty[J]. J Am Coll Cardiol, 1996,27:819-824.
4Gawaz M, Neumann FJ, Ott I, et al . Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis[J]. Coron Artery Dis, 1997, 8:121-128.
5Neumann FJ, Gawaz M, Ott I, et al . Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schaz stenting[J]. J Am Coil Cardiol, 1996, 27:15-21.
6Moussa I. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation[ J]. Circulation, 1999,99 : 2364-2366.
7Sehulen H, Kastrati A, Dirschinger J, et al . Intracoronary stenting and risk for major adverse cardiac events during the first month[Jl.Circulation, 1998,98:104-111.
8Cheneau E, Leborgne L, Mintz GS, et al . Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study[J]. Circulation, 2003, 108:43-47.
9Honda Y, Fitzgerald PJ. Stent thrombosis-an issue revisited in a changing world[J]. Circulation, 2003, 108:2-5.
10Gurbel PA, Callahan KP, Malinin AL, et al . Could stent design affect platelet activation? Results of the Platelet Activation in Stenting(PAST) study[J]. J Inves Cardiol, 2002, 14:584-589.
